Integer (NYSE:ITGR) VP Tommy Thomas Sells 825 Shares

Integer Holdings Corporation (NYSE:ITGR) VP Tommy Thomas sold 825 shares of the company’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the completion of the transaction, the vice president owned 4,381 shares in the company, valued at $372,385. This trade represents a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Integer Stock Performance

Integer stock traded up $3.05 during midday trading on Tuesday, hitting $87.17. The company’s stock had a trading volume of 837,685 shares, compared to its average volume of 825,684. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. The company has a market cap of $3.00 billion, a price-to-earnings ratio of 30.37, a PEG ratio of 1.41 and a beta of 0.75. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $127.56. The company has a 50-day moving average price of $85.32 and a two-hundred day moving average price of $85.52.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.06. Integer had a net margin of 5.55% and a return on equity of 13.26%. The firm had revenue of $472.06 million for the quarter, compared to analyst estimates of $462.73 million. During the same quarter in the prior year, the business posted $1.43 EPS. The business’s revenue was up 5.0% compared to the same quarter last year. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. As a group, sell-side analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Wall Street Analyst Weigh In

ITGR has been the subject of a number of recent analyst reports. Wells Fargo & Company upped their target price on Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, February 20th. Truist Financial boosted their target price on shares of Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Friday, February 20th. Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Citigroup lifted their price objective on shares of Integer from $75.00 to $92.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Finally, Wall Street Zen downgraded shares of Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Four equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $102.00.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Tudor Investment Corp ET AL grew its holdings in shares of Integer by 50,787.5% during the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock valued at $28,606,000 after purchasing an additional 29,442,029 shares during the last quarter. Irenic Capital Management LP bought a new position in Integer in the 4th quarter valued at approximately $99,109,000. Alliancebernstein L.P. boosted its position in Integer by 885.1% in the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock valued at $136,016,000 after buying an additional 993,810 shares in the last quarter. Millennium Management LLC grew its stake in shares of Integer by 3,350.2% during the fourth quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock worth $53,106,000 after buying an additional 657,483 shares during the last quarter. Finally, J. Goldman & Co LP bought a new stake in shares of Integer during the fourth quarter worth $40,531,000. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.